|
Dec 1
|
Here's Why InflaRx N.V. (IFRX) Looks Ripe for Bottom Fishing
|
|
Nov 28
|
After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX)
|
|
Aug 10
|
InflaRx Reports Second Quarter 2023 Financial Results & Operating Update
|
|
Apr 7
|
Why InflaRx Stock Skyrocketed This Week
|
|
Apr 5
|
Why Shares of InflaRx Are Soaring Wednesday
|
|
Apr 5
|
InflaRx (IFRX) Stock Up on FDA's EUA for COVID-19 Treatment
|
|
Apr 4
|
UPDATE 1-InflaRx COVID injection gets US FDA's emergency-use authorization
|
|
Apr 4
|
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
|